48,830
edits
m |
m (→Associations - DDx: refs) |
||
Line 19: | Line 19: | ||
==Associations - DDx== | ==Associations - DDx== | ||
*Infections.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref><ref> | *Infections.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref><ref>{{Ref_PBoD|261}}</ref> | ||
**Tuberculosis. | **Tuberculosis. | ||
**Leprosy. | **Leprosy. | ||
Line 31: | Line 31: | ||
*Malignancy. | *Malignancy. | ||
**Plasmacytoma. | **Plasmacytoma. | ||
***5-15% of patients with multiple myeloma develop amyloidosis<ref> | ***5-15% of patients with multiple myeloma develop amyloidosis<ref>{{Ref_PBoD|261}}</ref> - some say 10-20%.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref> | ||
**Medullary thyroid carcinoma. | **Medullary thyroid carcinoma. | ||
**Renal cell carcinoma. | **Renal cell carcinoma. |
edits